Found 172 matching trials
Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) PHASE2 This study is a prospective cohort clinical trial that aims to investigate ...
Show More Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Learn More & Join Trial
Penpulimab Combined With Chemotherapy for Neoadjuvant and Adjuvant Therapy in Patients With Resectable HNSCC PHASE2 This study aims to observe and explore the efficacy and safety of Penpulima...
Show More Location
Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) PHASE3 This is an international phase III trial, with a Bayesian design, incorpora...
Show More Location
Los Angeles County-USC Medical Center
Learn More & Join Trial
Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer PHASE2 To compare outcomes between the CRS group and the control group in patients...
Show More Location
National Cancer Center, Korea
Learn More & Join Trial
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002) PHASE3 The purpose of this study is to evaluate the efficacy and safety of pembrol...
Show More Location
Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Cetuximab + Tislelizumab + Chemotherapy in the Treatment of Unresectable LA HNSCC PHASE2 This prospective, single-arm, Phase II study aims to evaluate the efficacy,...
Show More Location
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer PHASE2 This study will evaluate the surgical safety and feasibility of atezolizuma...
Show More Location
City of Hope Cancer Center
Learn More & Join Trial
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009) PHASE3 The goal of this study is to learn if people who receive intismeran autogen...
Show More Location
Banner MD Anderson Cancer Center ( Site 0181)
Learn More & Join Trial
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer PHASE3 Histological Node Negative thoracic esophageal squamous cell carcinoma(pN0 ...
Show More Location
Shanghai Chest Hospital
Learn More & Join Trial
Neoadjuvant Zanidatamab + Tislelizumab + Chemotherapy for Selective Bladder Preservation in HER2-Positive MIBC PHASE2 This is a multicenter, open-label, prospective, single-arm, phase II study ...
Show More Location
Fujian Medical University Union Hospital
Learn More & Join Trial